By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Cheap Generic Drugs from Emerging Markets Risky
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Global Healthcare > Cheap Generic Drugs from Emerging Markets Risky
BusinessGlobal Healthcare

Cheap Generic Drugs from Emerging Markets Risky

JohnCGoodman
JohnCGoodman
Share
1 Min Read
SHARE

Poorly made medicines are a greater threat than counterfeit medications, according to Roger Bate and Julissa Milligan of the American Enterprise Institute in Washington. They write:

Poorly made medicines are a greater threat than counterfeit medications, according to Roger Bate and Julissa Milligan of the American Enterprise Institute in Washington. They write:

Patients in emerging markets want greater access to medicines, but supplying medicines cheaply is proving problematic. Part of the difficulty is the proliferation of illegal counterfeits in the poorest markets. Yet our new research shows that substandard medicines—those legally but poorly produced—pose an equally dangerous threat to patients.

Production flaws in developing countries will only be exacerbated by lower quality chemicals inputs from China, the world’s largest chemical supplier. Ingredients from India and China are now found in 80 percent of American pharmaceuticals and probably in higher volumes elsewhere.

More Read

mammogram
When Is a Mammogram Not a Mammogram?
Why Video Matters in Hospital Marketing
Medicaid Expansion a Real Budget-Buster
Pioneering Healthcare in Brazil
About Time: Health Care Firms Send Jobs Overseas

Meanwhile, African manufacturers performed worst, yielding 8.3 percent failures overall, followed by Chinese, Vietnamese, and small Indian producers. In emerging markets, domestically made products were far more likely to fail than imported products.

   

TAGGED:global healthcarehealthcare businesspharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Cash Transfers: Good for HIV/AIDS Too

August 9, 2012
obamacare an covered california
BusinessFinanceHealth ReformPolicy & LawPublic Health

Obamacare and Reimbursement Rates to Providers

December 11, 2013

Beyond Ebola: Doximity and Doctors Without Borders Work to Fight Infectious Disease

October 23, 2014
Image
eHealthGlobal HealthcareMedical EducationMedical RecordsMobile HealthRemote DiagnosticsSocial MediaTechnology

#Doctors20 & You Conference: #mHealth, #ePatients, #Collaboration

May 25, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?